|

Anti-Tumor Necrosis Factor Alpha Drug (Product) Clinical Trials

1 actively recruiting trial

Also known as: Adalimumab (Humira) Etanercept (Enbrel)

Pipeline

Phase 4: 1

Top Sponsors

  • R.Bos1

Indications

  • Arthritis1
  • Rheumatoid Arthritis1

Other1 trial

Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.